Francis Medical, Inc. develops medical technology for targeted tissue ablation, including the Vanquish System designed for water vapor prostate treatment.
Subscribe to see Francis Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Francis Medical, Inc. is a medical devices company headquartered in United States. It has raised at least $60M across the 2 funding rounds on record. Its most recent funding round raised $40M in December 2024. Xcout tracks 18 named people at Francis Medical, Inc., including Michael Kujak (President and CEO).
12 more named people on record for Francis Medical, Inc., with roles, board committees and tenure — see the full roster →
At least $60M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $40M | — | |
| SEC Form D filing | $20M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Francis Medical, Inc.'s closest competitors — see the full list of competitors and alternatives →
Focal Medical develops and manufactures the Focal One HIFU Robotic System, a non-invasive medical device that utilizes high-intensity focused ultrasound technology to precisely target and ablate prostate tissue. The company serves urologists and healthcare facilities by providing equipment for prostate cancer management that preserves healthy surrounding tissue and minimizes side effects for patients.
Vessi Medical is a medical technology company headquartered in Nesher, Israel. The company is developing an innovative, IP-protected cryo spray designed for hollow and humid organs, introducing a novel approach to the treatment of urological tissue.
Focal Therapeutics provides the Focal One robotic system, which utilizes high-intensity focused ultrasound (HIFU) technology to non-invasively target and ablate prostate tissue for prostate cancer patients. The system is designed for urologists to precisely treat targeted lesions while sparing healthy surrounding tissue and minimizing side effects.
Innoblative Designs, Inc. is a private medical device company addressing clinical unmet needs for patients through innovative surgical ablation solutions.
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
Zenflow, Inc. is a medical equipment manufacturing company that develops minimally invasive treatments for benign prostatic hyperplasia (BPH), with headquarters in South San Francisco, California.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.